Advertisement
A high percentage of women receiving a new HIV diagnosis have already received this diagnosis in the past but are not undergoing HIV medical care

High Percentage of HIV-Diagnosed Women Not in Care

0
62 percent of women with positive test had previously received the diagnosis but no care
Aspirin therapy is associated with a reduced risk of hepatitis B virus-related hepatocellular carcinoma

For Hepatitis B Patients, Aspirin Tied to Lower Risk of HCC

0
5 years of aspirin therapy linked to significantly lower incidence of hepatocellular carcinoma
A highly pathogenic H7N9 avian influenza variant has evolved and now has the potential to cause a pandemic

H7N9 Avian Influenza May Be Capable of Pandemic

0
Virus spread via respiratory droplets in animal study; neuraminidase inhibitors showed limited efficacy
Key stakeholders and physicians discussed electronic health record usability and optimization in the American Medical Association Running Your Practice Community.

Key Stakeholders Discuss How to Make EHRs More Usable

0
Stakeholders, physicians discuss EHR usability and optimization, rules for releasing test results
Intravenous (IV) hydromorphone is less effective than IV prochlorperazine plus diphenhydramine for acute migraine treatment in the emergency department

IV Prochlorperazine Beats IV Hydromorphone for Migraine

0
IV hydromorphone much less effective for migraine treatment in the emergency department
For patients with active psoriatic arthritis who have an inadequate response to tumor necrosis factor inhibitors or to conventional synthetic disease-modifying antirheumatic drugs

Tofacitinib Superior to Placebo in Active Psoriatic Arthritis

0
Tofacitinib is superior for patients with inadequate response to TNF inhibitors or conventional DMARDs
Yescarta (axicabtagene ciloleucel) has been approved by the U.S. Food and Drug Administration for individuals with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.

Gene Tx Approved for Certain Types of B-Cell Lymphoma

0
First such treatment for certain types of non-Hodgkin lymphoma
Oral semaglutide is associated with better glycemic control than placebo among type 2 diabetes patients with insufficient glycemic control

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

0
Phase 3 studies next to assess longer-term/clinical outcomes, safety
For patients with venous thromboembolism

No Increased Risks for DOAC Use Versus Warfarin in VTE

0
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism
Introduction of an HIV pre-exposure prophylaxis program for men who have sex with men in the United Kingdom is likely to be cost-effective

Pre-Exposure Prophylaxis for Homosexual Men Cost-Effective

0
Introduction of HIV PrEP program cost-effective and possibly cost-saving for men who have sex with men